Načítá se...

Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas

Mining modern genomics for cancer therapies is predicated on weeding out “bystander” alterations (nonconsequential mutations) and identifying “driver” mutations responsible for tumorigenesis and/or metastasis. We used a direct in vivo RNA interference (RNAi) strategy to screen for genes that upon re...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schramek, Daniel, Sendoel, Ataman, Segal, Jeremy P., Beronja, Slobodan, Heller, Evan, Oristian, Daniel, Reva, Boris, Fuchs, Elaine
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4159249/
https://ncbi.nlm.nih.gov/pubmed/24436421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1248627
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!